Status | Study |
Recruiting |
Study Name: Benzbromarone-Controlled, Double-Blind, Comparative Study of FYU-981 in Hyperuricemia With or Without Gout Condition: Hyperuricemia With or Without Gout Date: 2017-03-29 Interventions: Drug: FYU-981 Oral daily dosin |
Recruiting |
Study Name: The Drug-Drug Interaction of SHR4640, Febuxostat and Colchicine in Patients With Gout Condition: Gout Date: 2017-02-27 Interventions: Drug: Colchicine Day-14~Day16 |
Recruiting |
Study Name: Study of FYU-981 in Hyperuricemia With or Without Gout Condition: Hyperuricemia With or Without Gout Date: 2016-12-28 Interventions: Drug: FYU-981 |
Recruiting |
Study Name: A Study to Evaluate Efficacy and Safety of Anakinra in the Treatment of Acute Gouty Arthritis Condition: Acute Gouty Arthritis Date: 2016-12-13 Interventions: Drug: Anakinra 100 mg 100 mg/0 |
Recruiting |
Study Name: Multi-Dose Safety/Pharmacodynamic Study of SEL-212/SEL-037 in Subjects With Symptomatic Gout & Elevated Blood Uric Acid Condition: Gout Chronic Hyperuricemia Date: 2016-11-06 Interventions: Drug: SEL-212 SEL-212 |
Recruiting |
Study Name: Novel Methods for Ascertainment of Gout Flares -A Pilot Study Condition: Gout Date: 2016-07-28 Interventions: Device: IVR (Phone call) IVR w |
Active, not recruiting |
Study Name: Virtual Gout Clinic Condition: Gout Date: 2016-05-31 Interventions: Behavioral: Pharmacist-Led Intervention Pharmacists will conduct outreach primarily via an automated tel |
Not yet recruiting |
Study Name: SToRytelling to Improve DiseasE Outcomes in GOut: The STRIDE-GO 2 Study Condition: Gout Low Medication Adherence Health Related Quality of Li Date: 2016-03-21 Interventions: Behavioral: Improvement of Medication Adherence The investigators have developed a storytelling interven |
Active, not recruiting |
Study Name: Efficacy and Safety of HuZhen Capsule for Treatment of Patients With Acute Gout Condition: Acute Gout Date: 2016-01-28 Interventions: Drug: HuZhen Capsule Patients |
Completed |
Study Name: Study of URC102 to Assess the Safety and Efficacy in Gout Patients Condition: Gout Hyperuricemia Date: 2015-09-16 Interventions: Drug: URC102 Drug: Placebo |